Wanbury Q1 FY27 Results: PAT Falls 76% YoY, ESOP Allotment, Director Re-appointment

Exceptional ItemResults View source PDF Explain this filing

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹256.50

prior close

₹243.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+1.9% vs market

Pharmaceuticals peers, median of 165sector-0.6%+2.9% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+8.4

10m

+1.4

15m

-1.0

30m

-3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3+0.4+1.9-0.6+2.9

Next day

-2.3+0.5-2.9-0.3-2.1

+0.2+0.6-0.4-0.7+0.9

-2.0+0.7-2.7-1.4-0.6

-0.2+1.1-1.3-1.1+0.9

+4.5+0.5+4.0-2.0+6.4

+3.0+1.3+1.7-1.4+4.4

15d

-4.5+0.5-5.0-0.9-3.6

-12.3-0.8-11.4-0.2-12.1

-25.2-0.9-24.2-3.2-22.0

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Wanbury Limited reported Q1 FY27 (June 2026) revenue of Rs.16,558 lakhs, up 1.5 percent YoY from Rs.16,318 lakhs. However, profit after tax fell sharply to Rs.324 lakhs from Rs.1,349 lakhs (down 76 percent YoY). Basic EPS stood at Rs.0.93 versus Rs.4.12. The board allotted 27,530 equity shares under ESOP 2016 and re-appointed Mr. Mohan Kumar Rayana as Whole-time Director for 5 years. Company also raised Rs.205 crore NBFC borrowings to replace high-cost debt, releasing 85.2 lakh pledged promoter shares.

Likely market impact

Sharp PAT decline despite flat revenue signals margin pressure. ESOP allotment is minor dilution. Director continuity is positive for stability.